Clinical Trials Browser

Recurrence × Vinorelbine × Clear all

NCT07406542 2026-02-12

A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast Cancer

Phase 3 Not yet recruiting

Breast Neoplasms, Recurrence

NCT05300282 2026-01-28

FIL_A-BEGEV

Phase 1/2 Recruiting

Hodgkin Disease, Recurrence

NCT03618550 2025-12-02

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Phase 2 Recruiting

Hodgkin Disease, Recurrence

NCT03443128 2025-02-13

Vinorelbine for Recurrent ALCL-2017

Phase 2 Completed

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT00574496 2023-09-28

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Phase 2 Completed

25 enrolled 10 charts

Hodgkin Disease, Lymphoma, Recurrence

NCT03397953 2022-07-26

Vinorelbine for Recurrent ACLC

Phase 2 Completed

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT00381940 2021-03-24

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

Phase 2 Completed

26 enrolled 14 charts

Hodgkin Disease, Recurrence

NCT02733380 2020-04-01

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Phase 2 Unknown

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT00597116 2016-10-10

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

Phase 2 Terminated

25 enrolled 8 charts

Other solid neoplasmThoracic

Mesothelioma, Recurrence

NCT00006029 2016-07-14

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase 1/2 Completed

Hodgkin Disease, Lymphoma, Recurrence

NCT02281708 2014-11-03

Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma

Phase 3 Unknown

Lung Neoplasms, Recurrence

NCT01884441 2014-01-29

Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients

Phase 2 Unknown

Hodgkin Disease, Lymphoma, Recurrence

NCT00006760 2013-07-26

Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma, Recurrence

NCT00070304 2013-07-26

Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma, Recurrence